Prime Capital Funding Advisors LLC decreased its stake in GE HealthCare Applied sciences Inc. (NASDAQ:GEHC – Free Report) by 10.9% within the third quarter, in line with the corporate in its most up-to-date disclosure with the Securities and Trade Fee. The agency owned 4,422 shares of the corporate’s inventory after promoting 542 shares through the interval. Prime Capital Funding Advisors LLC’s holdings in GE HealthCare Applied sciences had been price $415,000 as of its most up-to-date submitting with the Securities and Trade Fee.
Different hedge funds additionally not too long ago made adjustments to their positions within the firm. Capital Analysis International Buyers boosted its place in GE HealthCare Applied sciences by 5.2% through the first quarter. Capital Analysis International Buyers now owns 53,991,923 shares of the corporate’s inventory valued at $4,908,406,000 after buying a further 2,647,204 shares over the past quarter. Vanguard Group Inc. grew its stake in GE HealthCare Applied sciences by 9.2% through the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the corporate’s inventory price $4,410,893,000 after buying a further 4,107,746 shares through the interval. Van ECK Associates Corp purchased a brand new stake in GE HealthCare Applied sciences within the third quarter price roughly $208,513,000. The Producers Life Insurance coverage Firm lifted its stake in GE HealthCare Applied sciences by 18.0% within the second quarter. The Producers Life Insurance coverage Firm now owns 1,245,961 shares of the corporate’s inventory valued at $97,088,000 after shopping for a further 189,956 shares through the interval. Lastly, Sumitomo Mitsui Belief Group Inc. lifted its stake in GE HealthCare Applied sciences by 2.3% within the third quarter. Sumitomo Mitsui Belief Group Inc. now owns 1,022,396 shares of the corporate’s inventory valued at $95,952,000 after shopping for a further 23,448 shares through the interval. 82.06% of the inventory is at the moment owned by institutional traders.
Insider Shopping for and Promoting
In different information, CEO Roland Rott offered 3,577 shares of the agency’s inventory in a transaction that occurred on Wednesday, November sixth. The shares had been offered at a mean value of $86.48, for a complete transaction of $309,338.96. Following the completion of the sale, the chief government officer now owns 24,298 shares within the firm, valued at $2,101,291.04. This commerce represents a 12.83 % lower of their place. The sale was disclosed in a doc filed with the SEC, which is obtainable at this hyperlink. 0.27% of the inventory is owned by insiders.
Analysts Set New Worth Targets
GEHC has been the subject of a number of analysis analyst studies. Wells Fargo & Firm elevated their goal value on shares of GE HealthCare Applied sciences from $95.00 to $96.00 and gave the inventory an “chubby” score in a analysis notice on Thursday, October thirty first. Evercore ISI raised their goal value on GE HealthCare Applied sciences from $98.00 to $102.00 and gave the corporate an “outperform” score in a analysis notice on Tuesday, October 1st. Stifel Nicolaus upped their value goal on GE HealthCare Applied sciences from $100.00 to $102.00 and gave the inventory a “purchase” score in a analysis notice on Monday, September thirtieth. JPMorgan Chase & Co. initiated protection on GE HealthCare Applied sciences in a analysis notice on Monday, September ninth. They issued a “impartial” score and a $90.00 value goal for the corporate. Lastly, BTIG Analysis raised GE HealthCare Applied sciences from a “impartial” score to a “purchase” score and set a $100.00 goal value on the inventory in a analysis report on Wednesday, September 18th. One equities analysis analyst has rated the inventory with a promote score, 5 have given a maintain score, eight have issued a purchase score and one has issued a powerful purchase score to the corporate. In accordance with knowledge from MarketBeat.com, the corporate presently has a mean score of “Average Purchase” and a mean goal value of $94.36.
Learn Our Newest Report on GEHC
GE HealthCare Applied sciences Inventory Efficiency
Shares of GEHC inventory opened at $81.76 on Friday. The corporate has a debt-to-equity ratio of 1.12, a present ratio of 1.23 and a fast ratio of 0.98. The agency has a 50-day transferring common of $88.70 and a 200-day transferring common of $83.48. GE HealthCare Applied sciences Inc. has a one yr low of $66.39 and a one yr excessive of $94.55. The corporate has a market cap of $37.35 billion, a P/E ratio of twenty-two.46, a P/E/G ratio of three.02 and a beta of 1.24.
GE HealthCare Applied sciences (NASDAQ:GEHC – Get Free Report) final posted its quarterly earnings knowledge on Wednesday, October thirtieth. The corporate reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. The agency had income of $4.86 billion through the quarter, in comparison with analyst estimates of $4.87 billion. GE HealthCare Applied sciences had a internet margin of 8.56% and a return on fairness of 25.19%. The corporate’s income for the quarter was up .9% on a year-over-year foundation. Throughout the identical quarter final yr, the enterprise posted $0.99 EPS. Equities analysis analysts forecast that GE HealthCare Applied sciences Inc. will submit 4.29 EPS for the present fiscal yr.
GE HealthCare Applied sciences Dividend Announcement
The agency additionally not too long ago introduced a quarterly dividend, which was paid on Friday, November fifteenth. Stockholders of report on Friday, October 18th had been paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized foundation and a dividend yield of 0.15%. The ex-dividend date of this dividend was Friday, October 18th. GE HealthCare Applied sciences’s payout ratio is 3.30%.
GE HealthCare Applied sciences Profile
GE HealthCare Applied sciences Inc engages within the improvement, manufacture, and advertising of merchandise, providers, and complementary digital options used within the analysis, therapy, and monitoring of sufferers in the US, Canada, and internationally. The corporate operates by means of 4 segments: Imaging, Ultrasound, Affected person Care Options, and Pharmaceutical Diagnostics.
Beneficial Tales
Obtain Information & Scores for GE HealthCare Applied sciences Day by day – Enter your e mail handle beneath to obtain a concise day by day abstract of the newest information and analysts’ scores for GE HealthCare Applied sciences and associated corporations with MarketBeat.com’s FREE day by day e mail publication.
